By Scott Gilbert, Penn Statte
Penn State College of Medicine has just received a $3.9 million award from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health for research to find biomarkers for Parkinson’s disease.
Parkinson’s disease is a chronic and progressive movement disorder that affects more than 1 million Americans.
The five-year award is part of the Parkinson’s Disease Biomarkers Program of the NINDS that is designed to find reliable markers that can be used in the future evaluation of novel therapies that may stop Parkinson’s.
Professor Xuemei Huang of Penn State Hershey Medical Center has been an active researcher in this field. The new award will be based on recent results from her laboratory that suggest a novel way to detect Parkinson’s related brain damage by using a commonly available clinical technique, magnetic resonance imaging (MRI).
“In Parkinson’s, there is currently no widely available way to detect cell-loss in the brain for use in diagnosing the disease or tracking its progression,” Huang said. “We are looking for ways to reliably show Parkinson’s disease-related changes in patients’ brains without having to perform any invasive procedures.”
The National Institute of Neurological Disorders and Stroke created the Parkinson’s Disease Biomarkers Program in 2011. The program supports research related to discovering biomarkers and also creates a mechanism that promotes the sharing of biological samples and related data to help speed discovery of new therapeutic approaches. The award to Penn State Hershey under this initiative is one of only nine projects funded nationwide.
“Dr. Xuemei Huang, an outstanding investigator and clinician in the Penn State Hershey Department of Neurology, epitomizes the efforts of the Penn State Hershey Neuroscience Institute to foster neuroscience research, teaching and patient care,” said Dr. Robert Harbaugh, director, Penn State Hershey Neuroscience Institute. She is one of a large number of physicians and scientists in the Neuroscience Institute who are leading the way in providing new scientific discoveries in Parkinson’s disease and using this knowledge to develop more effective care.”